CD44 antibody (C-Term)
Quick Overview for CD44 antibody (C-Term) (ABIN6242234)
Target
See all CD44 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 688-722, C-Term
-
Purification
- This antibody is purified through a protein A column, followed by peptide affinity purification..
-
Immunogen
-
Target/Specificity: This CD44 antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 688-722 amino acids from the C-terminal region of human CD44.
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
-
-
Role of thioredoxin reductase 1 in dysplastic transformation of human breast epithelial cells triggered by chronic oxidative stress." in: Scientific reports, Vol. 6, pp. 36860, (2018) (PubMed).
: "The Role of CD44 in Glucose Metabolism in Prostatic Small Cell Neuroendocrine Carcinoma." in: Molecular cancer research : MCR, Vol. 14, Issue 4, pp. 344-53, (2017) (PubMed).
: "All-trans retinoic acids induce differentiation and sensitize a radioresistant breast cancer cells to chemotherapy." in: BMC complementary and alternative medicine, Vol. 16, pp. 113, (2016) (PubMed).
: "
-
Role of thioredoxin reductase 1 in dysplastic transformation of human breast epithelial cells triggered by chronic oxidative stress." in: Scientific reports, Vol. 6, pp. 36860, (2018) (PubMed).
-
- CD44
-
Alternative Name
- CD44
-
Background
- CD44 antigen, CDw44, Epican, Extracellular matrix receptor III, ECMR-III, GP90 lymphocyte homing/adhesion receptor, HUTCH-I, Heparan sulfate proteoglycan, Hermes antigen, Hyaluronate receptor, Phagocytic glycoprotein 1, PGP-1, Phagocytic glycoprotein I, PGP-I, CD44, CD44, LHR, MDU2, MDU3, MIC4
-
Molecular Weight
- 81538
-
UniProt
- P16070
-
Pathways
- Glycosaminoglycan Metabolic Process, Autophagy, Negative Regulation of intrinsic apoptotic Signaling
Target
-